期刊文献+

单链抗体的生物学特性及其在肿瘤和艾滋病诊断治疗中的应用 被引量:1

暂未订购
导出
摘要 单链抗体是一种基因工程小分子抗体 ,其基本结构为VH Linker VL 或VL Linke VH。单链抗体由于具有免疫原性低、在血液中清除快、肿瘤穿透力强和特异性强等优点 ,而在疾病的诊断、治疗和预防及其研究方面有着十分重要的应用价值 ,本文就单链抗体的生物学特性及其在肿瘤和艾滋病诊断治疗中的应用作一综述。
出处 《现代免疫学》 CAS CSCD 北大核心 2004年第3期253-255,共3页 Current Immunology
  • 相关文献

参考文献3

二级参考文献8

  • 1Bukrinsky M,Sharova N,Stevenson M.Human immunodeficiency virus t ype 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex〔J〕[].Journal of Virology.1989
  • 2Cannon P M,Byles ED,Kingsman SM,et al.Conserved sequences in the carboxyl terminus of integrase that are essential for human immun odeficiency virus t ype 1 replication〔J〕[].Journal of Virology.1996
  • 3Kulkosky J,Skalka AM.Molecular mechanism of retroviral DNA integration〔J〕[].Pharmacology and Therapeutics.1994
  • 4Lutzke RA,Vink C,Plasterk RH.Characterization of the minmal DNA-binding domains of the HIV integrase protein〔J〕[].Nucleic Acids Research.1994
  • 5Engelman A,Englund G,Orenstein JM,et al.Multi ple effects of mutations in human immunodeficiency virus t ype 1 integrase on viral replication〔J〕[].Journal of Virology.1995
  • 6Engelman A,Hickman AB,Crai gie R.The core and carboxylterminal domains of the integrase protein of human immumodeficiency virus t ype 1 each contribute to nonspecific DNA binding〔J〕[].Journal of Virology.1994
  • 7Farnet CM,Haseltine WA.Circularization of human immunodeficiency virus t ype 1 DNA in vitro〔J〕[].Journal of Virology.1991
  • 8Pauza CD,Galindo J.Persistent human immunodeficiency virus t ype 1 infection of monoblastoid cells leads to accumulation of self-integrated viral DNA and to production of defective virions〔J〕[].Journal of Virology.1989

共引文献1

同被引文献17

  • 1粘红,安利国,赵岩,陈吉中,范国才,王清明.抗肝癌细胞噬菌体单链抗体库的构建及筛选[J].现代免疫学,2004,24(5):357-361. 被引量:1
  • 2杨乔欣,马文煜,孙苗,陈常庆.抗单纯疱疹病毒CHA9-3D8单链抗体三维结构的计算机模建和分析[J].细胞与分子免疫学杂志,1997,13(1):28-33. 被引量:1
  • 3Denton G, Sekowski M, Spencer DI, etal. Production and characterization of a recombinant anti-MUC1 seFv reactive with human carcinomas[J]. Br J Cancer, 1997, 76: 614-621.
  • 4Holmes MA, Buss TN, Foote J. Structural effects of frame work mutations on a humanized anti-lysozyme antibody[J]. J Immunol, 2001, 167: 296-301.
  • 5Shapiro GS, Aviszus K, Ikle D, et al. Predicting regional mutability in antibody V genes based solely on di- and trinueleotide sequence composition[J]. J Immunol, 1999, 163: 259-268.
  • 6Winter G, Harris WJ. Humanized antibodies[J]. Immunol Today, 1993, 14: 243-246.
  • 7Riechmann L, Clark M, Waldmann H, etal. Reshapinghuman antibodies for therapy[J]. Nature, 1988, 332: 323-327.
  • 8Bhat TN, Bentley GA, Fischmann TO, et al. Small rear- rangement in structures of Fv and Fab fragments of antibody D1. 3 on antigen binding[J]. Nature, 1990, 347: 483-485.
  • 9Arnold K, Bordoli L, Kopp J, et al. The SWISS-MODEL Workspace: A web-based environment for protein structure homologymodeling[J]. Bioinformatics, 2006, 22: 195-201.
  • 10Schwede T, Kopp J, Guex N, et al. SWISS-MODEL: an automated protein homology-modeling server [J]. Nucleic Acids Research, 2003, 31: 3381-3385.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部